---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-010637"
form_type: "8-K"
ticker: "TRVI"
cik: "0001563880"
company_name: "Trevi Therapeutics, Inc."
filed_at: "2022-03-16T23:59:59+00:00"
generated_at: "2026-06-26T22:21:25.466182+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Trevi Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq deficiency letter on Jan 10, 2022 for bid price below $1 for 30 consecutive days.
- Compliance regained after closing bid price above $1 for ten consecutive business days (March 2-15, 2022).
- Nasdaq notified company on March 16, 2022 that the matter is closed.
- Company's common stock remains listed on Nasdaq Global Market.

## SEC filing metadata
- accession: 0001564590-22-010637
- form_type: 8-K
- ticker: TRVI
- cik: 0001563880
- company_name: Trevi Therapeutics, Inc.
- filed_at: 2022-03-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563880/000156459022010637/0001564590-22-010637-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563880/000156459022010637/trvi-8k_20220316.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-010637
- JSON: https://secwatch.observer/filing/0001564590-22-010637.json
- Plain text: https://secwatch.observer/filing/0001564590-22-010637.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.